Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
Application Deadline 1 Mar 2026 - 22:59 (UTC) Type of Contract Permanent Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to
-
Researcher (R2) Country Belgium Application Deadline 15 Feb 2026 - 22:59 (UTC) Type of Contract Permanent Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU
-
Deadline 15 Feb 2026 - 22:59 (UTC) Type of Contract Permanent Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff
-
Context The ICT Directorate has around 100 employees in total and is divided into five departments: Operations & Infrastructure, Service Center, Scientific Data & Compute, Applications, and the
-
Feb 2026 - 22:59 (UTC) Type of Contract Permanent Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position
-
Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description → Apply before 23/12/2025 (DD/MM/YYYY) 23:59 (Brussels Time) → Faculty
-
the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description → Apply until 27/10
-
diverse academic backgrounds to contribute to our projects in areas such as: Network Security, Information Assurance, Model-driven Security, Cloud Computing, Cryptography, Satellite Systems, Vehicular
-
Researcher (R2) Country Belgium Application Deadline 2 Mar 2026 - 22:59 (UTC) Type of Contract Temporary Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU
-
field of molecular and computational genomics of Alzheimer’s disease. The Sleegers lab is an international team committed to increasing insights into the complex genetics of Alzheimer’s disease and to